Bookmark and Share rss


 


Robert Jones MA PhD read Natural Sciences at Cambridge University. Entering cancer research in 1959, he was awarded a PhD in pathology in 1966. He has held appointments at the Royal College of Surgeons and London medical schools. He has worked in the Universities of Munich and Tubingen and at the German Cancer Research Centre at Heidelberg.

Although cancer has been his major professional interest, Dr. Jones has published original work on histochemistry, quantitative analysis, reagent design and synthesis, organ transplantation and toxicology.

Dr. Jones' biggest breakthrough has been finding a way, using an over-the-counter medication called Promethazine (Phenergan) along with specific health supplements, to alter cancer cells' mitochondrial energy metabolism so that toxins are produced that kill off just the cancer cells. This is an effective, selective and inexpensive cancer treatment that allopathic medicine does not want you to know about.

If you are interested in knowing more about this cancer treatment, please use the link menu above. Dr. Jones has also written a book called In the Darker Shadow of Science covering this remarkable cancer treatment and the negative reaction to it from other doctors. This book is unfortunately out of print at the moment but a new revised edition should be published shortly.

Dr. Jones can be contacted at crackcancer@hotmail.com.

Robert Jones' book

Promethazine Cancer Treatment
Dr. Robert Jones' promising cancer protocol
Updated Edition - December 2008

The Promethazine or Phenergan® cancer treatment was developed by Robert Jones MA PhD as an effective and inexpensive means to kill cancer cells and increase survival rates.

Please note this guide is not a cancer treatment or a substitute for treatment. It has been compiled to help you find the right treatment for you. If you choose to go down the alternative or complimentary medicine path, we strongly advise that you do so under the supervision of a qualified healthcare practitioner.

 

PROMETHAZINE (known under the tradenames Phenergan®, Promethagan®, Romergan®, Fargan®, Prothiazine® and Avomine) is an over-the-counter medication used as an anti-histamine, a pediatric sedative and to quell travel sickness. Research by Dr. Robert Jones, however, has shown that, along with specific nutritional supplements, this medication is able to manipulate the mitochondrial metabolic pathways of cancer cells so that they produce toxins which kill only those cells.

Please use the menu on the top-right of this page to navigate between different pages of Dr. Jones' protocol, the most important of which is the TREATMENT section which outlines the actual cancer treatment programme. (There are also links on the bottom of each section to take you to the next section or the previous section.)

Please note that Dr. Jones is not pedaling a "magic bullet" all-cancer cure. He specifically lists contra-indications that should be read before deciding whether to embark on the program. You can find these listed in the TREATMENT paper. Amongst others they include steroid use, exposure to phenothiazines, analgesics (such as aspirin and ibuprofen) and multi-drug resistance. Finally, there is no evidence at the present time that this protocol is effective for prostatic, melanoma or mesothelioma cancers.

If you are interested in researching further into Dr. Robert Jones' work, he has written a book called In The Darker Shadow of Science — a narrative volume (in a similar vein to The Double Helix) that covers both the science and the politics of his research and why it has not been given the recognition that it deserves. If you have specific questions on his work, you can always email him [see right panel for Dr. Jones' email].

Finally and most importantly, although this is a self-medicating programme, we advise you to inform your doctor if you decide to follow it. Note that Dr. Jones is adamant that his cancer treatment programme is not "alternative medicine" as it is based entirely upon conventional medical research.

 

 

top  Bookmark and Share rss